» Articles » PMID: 26773570

Left Ventricular End-Systolic Eccentricity Index for Assessment of Pulmonary Hypertension in Infants

Overview
Date 2016 Jan 17
PMID 26773570
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pulmonary hypertension (PH) is a common problem in the neonatal intensive care unit and is associated with significant morbidity and mortality. The aim of this study was to identify a quantitative echocardiographic marker of septal curvature that can be used to accurately identify PH in NICU infants with concern for PH.

Methods: Echocardiograms of infants who were prematurely born and infants with persistent pulmonary hypertension of the newborn were performed using a defined protocol for evaluation of PH. Qualitative assessment by a single pediatric cardiologist was used as a reference standard. Qualitative and quantitative parameters of right ventricular (RV) size, pressure, and function were documented. Left ventricular end-systolic eccentricity index (EI) was defined as the ratio of the anterior-inferior and septal-posterolateral cavity dimensions at the mid-ventricular level.

Results: A total of 216 infants at risk for PH were included in this study. One hundred forty-three (66%) had an interpretable tricuspid regurgitation jet velocity. While systolic septal flattening was recognized at EIs ≥ 1.15, more than half-systemic RV pressure became apparent at EIs ≥ 1.3. Unlike qualitative assessment of septal flattening, there was high inter-observer agreement for EIs. Quantitative parameters of RV systolic function were impaired only at EIs ≥ 1.3.

Conclusions: We suggest that EIs should be incorporated into routine protocols when there is a concern for PH in neonates. This may lead to a more reliable assessment of PH and may reduce inter-observer variability. Correlation of EIs with invasive hemodynamic data is needed to validate our results.

Citing Articles

Risk Factors Associated With the Development of Late Pulmonary Artery Hypertension in Extremely Premature Infants.

Condit P, Hokanson J, Balasubramaniam V, McCulley D, Lasarev M, Lamers L Pediatr Pulmonol. 2025; 60(2):e27501.

PMID: 39945565 PMC: 11823566. DOI: 10.1002/ppul.27501.


Echocardiographic Predictors of Hospital Outcomes in Preterm Neonates with Patent Ductus Arteriosus and Clinical Suspicion of Pulmonary Hypertension.

Graff K, Ross J, Morella K, Chowdhury S J Neonatol. 2024; 37(4):384-389.

PMID: 39286053 PMC: 11402456. DOI: 10.1177/09732179231178127.


Biomarker screening for pulmonary hypertension in VLBW infants at risk for bronchopulmonary dysplasia.

Munoz F, Kim A, Kelly B, Jackson E, Evers P, Morrow D Pediatr Res. 2024; .

PMID: 39217263 DOI: 10.1038/s41390-024-03517-5.


Navigating Diagnostic and Treatment Challenges of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia.

Varghese N, Altit G, Gubichuk M, Siddaiah R J Clin Med. 2024; 13(12).

PMID: 38929946 PMC: 11204350. DOI: 10.3390/jcm13123417.


PDA management strategies and pulmonary hypertension in extreme preterm infants with bronchopulmonary dysplasia.

Hebert A, McNamara P, Carvalho Nunes G, Maltais-Bilodeau C, Leclerc M, Wutthigate P Pediatr Res. 2024; 97(1):325-332.

PMID: 38898108 DOI: 10.1038/s41390-024-03321-1.